180 Life Sciences Corp. CEO James Woody, MD, PhD Issues Letter to Shareholders
Yahoo! Finance
PALO ALTO, Calif., Jan. 31, 2022 (GLOBE NEWSWIRE) -- 180 Life Sciences Corp. (NASDAQ: ATNF, “180 Life Sciences” or the "Company"), a clinical-stage biotechnology company focused on the development of novel drugs that fulfill unmet needs in inflammatory diseases, fibrosis and pain, today released the following letter to shareholders from its Chief Executive Officer, Dr. James Woody. Dear Fellow Shareholders, As you may recall, I previously authored a letter to you at the end of August 2021. I con
Continue Reading